4.4 Article

The Prevalence of Serum Specific IgE to Superantigens in Asthma and Allergic Rhinitis Patients

Journal

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH
Volume 6, Issue 3, Pages 263-266

Publisher

KOREAN ACAD ASTHMA ALLERGY & CLINICAL IMMUNOLOGY
DOI: 10.4168/aair.2014.6.3.263

Keywords

Superantigen; specific IgE; allergic rhinitis; bronchial asthma

Funding

  1. Korea Science and Engineering Foundation (KOSEF) - Korea government [MEST 2013-003341]

Ask authors/readers for more resources

Staphylococcus aureus is the most common bacterium present in upper respiratory tract, and the toxins it produced are involved in allergic inflammation pathogenesis. In this study, we investigated the clinical significance of IgE in association with staphylococcal superantigens in allergic asthma with rhinitis (BAwAFR) and allergic rhinitis alone (AR). We recruited 100 patients with BAwAR (group I), 100 patients with AR (group II), and 88 healthy controls (group III). Patients were clinically diagnosed by physicians, and were sensitized to house dust mites. Specific IgE antibodies to staphylococcal superantigen A (SEA), B (SEB), and toxic shock syndrome toxin-1 (TSST-1) were measured using the ImmunoCAP system. Other clinical parameters were retrospectively analyzed. All specific IgE antibodies to SEA, SEB, and TSST-1 were detected most frequently in group 1(22%, 21%, and 27%), followed by group 11 (11%, 14%, and 21%) and group III (4.5%, 3.4%, and 2.3%). Absolute values of serum specific IgE to SEA, SEB, and TSST-1 were also significantly higher in group I (0.300 +/- 1.533 kU/L, 0.663 +/- 2.933 kU/L, and 0.581 +/- 1.931 kU/L) and group II (0.502 +/- 2.011 kU/L, 0.695 +/- 3.337 kU/L, and 1.067 +/- 4.688 kU/L) compared to those in group III (0.03 +/- 0.133 kU/L, 0.03 +/- 0.14 kU/L, and 0.028 +/- 0.112 kU/L). The prevalence of serum specific IgE to SEA was significantly higher in group I compared to group ll (P=0.025). Blood eosinophil counts were significantly higher in patients with specific IgE to SEA or SEB, and higher serum levels of specific IgE to house dust mites were noted in patients with specific IgE to TSST-1. In conclusion, the present study suggested that IgE responses to staphylococcal superantigens are prevalent in the sera of both BAwAR and AR patients. This may contribute to an augmented IgE response to indoor allergens and eosinophilic inflammation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Allergy

Real-World Disease Burden of Chronic Urticaria and Vaccine Hesitancy

Ga-Young Ban, Young -Min Ye

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2023)

Article Allergy

Anti-heat shock protein 10 IgG in chronic spontaneous urticaria: Relation with miRNA-101-5p and platelet-activating factor

Bo Youn Choi, Eun-Mi Yang, Hae-Won Jung, Min-Kyoung Shin, Junghyun Jo, Hyun-Young Cha, Hae-Sim Park, Ho-Chul Kang, Young-Min Ye

Summary: The study found a new autoantibody called anti-HSP10 IgG in patients with CSU, which showed a significant correlation with the severity of the disease. CSU patients had lower levels of HSP10 and higher levels of miR-101-5p compared to normal controls. MiR-101-5p promoted mast cell degranulation through upregulation of IL-4 and PAF, while HSP10 provided protection against it.

ALLERGY (2023)

Article Medicine, General & Internal

Treatment with biological products for chronic urticaria

Young-Min Ye

Summary: Chronic urticaria is a debilitating condition that significantly affects quality of life, and current treatment options, including antihistamines and omalizumab, are not effective for all patients. Ongoing research is investigating the therapeutic potential of other biological products targeting different aspects of the disease.

JOURNAL OF THE KOREAN MEDICAL ASSOCIATION (2023)

Article Medicine, General & Internal

Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient- Reported Outcomes After Vaccination

Ji-Won Kim, Ju-Yang Jung, Chang -Hee Suh, Young-Min Ye, Hyoun-Ah Kim

Summary: This study compared the occurrence of adverse events and disease flares after COVID-19 and influenza vaccination in patients with autoimmune rheumatic diseases (ARDs). The results showed that the rates of adverse events and disease flares were significantly higher after COVID-19 vaccination than after influenza vaccination. Previous allergic reactions to other vaccines were the only factor associated with the occurrence of adverse events. There was no difference in the post-vaccine response between mixed and matched vaccines.

JOURNAL OF KOREAN MEDICAL SCIENCE (2023)

Article Allergy

Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines

Mi-Ae Kim, Jeong-Hee Choi, Yoo-Seob Shin, Hae-Sim Park, Young-Min Ye

Summary: The prevalence of chronic urticaria (CU) is increasing globally and poses a significant burden on patients. This study compared the efficacy and safety of second-line treatments for CU refractory to standard doses of nonsedating H1-antihistamines (nsAHs). The results showed that increasing the dose of nsAHs four-fold and using a combination of multiple nsAHs were effective in controlling CU, but increasing the dose of nsAHs four-fold was more effective in achieving complete control of CU.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2023)

Letter Allergy

Functional Defects in B Lymphocytes in Asthmatic Patients With IgG Subclass Deficiency

Hyeukjun Sohn, Joo-Hee Kim, Jae-Hyuk Jang, Seung-Hyun Kim, Hae-Sim Park

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2023)

Article Allergy

Tissue Inhibitor of Metalloproteinase-1 Enhances Eosinophilic Airway Inflammation in Severe Asthma

Thi Bich Tra Cao, Quang Luu Quoc, Eun-Mi Yang, Ji-Young Moon, Yoo Seob Shin, Min Sook Ryu, Youngwoo Choi, Hae-Sim Park

Summary: This study found that tissue inhibitor of metalloproteinase-1 (TIMP-1) plays an important role in the pathogenesis of severe asthma (SA) by enhancing eosinophilic airway inflammation. Serum levels of TIMP-1 were significantly higher in asthmatics, especially in the SA group. There was a negative correlation between serum TIMP-1 levels and FEV1% values in SA patients. In vitro and in vivo experiments further confirmed that TIMP-1 can directly activate eosinophils and macrophages, induce the release of eosinophil extracellular traps, and promote macrophages to polarize towards the M2 subset, all of which can be suppressed by anti-TIMP-1 antibody.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2023)

Review Allergy

Bacterial Extracellular Vesicles: A Candidate Molecule for the Diagnosis and Treatment of Allergic Diseases

Youngwoo Choi, Hae-Sim Park, Yoon-Keun Kim

Summary: Extracellular vesicles (EVs) are released from various living cells and play important roles in intracellular communication. They contain proteins, lipids, and nucleic acids and can affect immune responses, contributing to health and disease. Bacterial EVs, a new area of research, have potential as immunomodulators for targeting asthma and atopic dermatitis.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2023)

Article Biochemistry & Molecular Biology

Micrococcus luteus-derived extracellular vesicles attenuate neutrophilic asthma by regulating miRNAs in airway epithelial cells

Soyoon Sim, Dong-Hyun Lee, Kwang-sun Kim, Hyeon Ju Park, Yoon-Keun Kim, Youngwoo Choi, Hae-Sim Park

Summary: Bacterial extracellular vesicles (EVs) from Micrococcus luteus have been found to regulate airway inflammation and improve lung function in asthma patients. These EVs specifically increase the levels of IgG4 and miRNA expression, which inhibit neutrophilic inflammation and improve respiratory symptoms. Therefore, MlEVs could be a potential novel therapeutic agent for managing neutrophilic asthma.

EXPERIMENTAL AND MOLECULAR MEDICINE (2023)

Review Allergy

Current Issues in the Management of IgG Subclass Deficiencies in Adults With Chronic Respiratory Diseases

Jae-Hyuk Jang, Joo-Hee Kim, Hae-Sim Park

Summary: This review provides an overview of the epidemiological data of immunoglobulin G subclass deficiency (IGGSCD) in adults, as well as detailed information on the investigation, treatment, and management strategies. IGGSCD is commonly found in patients with chronic respiratory diseases and can lead to severe respiratory complications.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2023)

Article Allergy

Stratification of clinical and inflammatory phenotypes according to the urinary leukotriene E4 level in adult asthmatics

Sangroc Kang, Jae-Hyuk Jang, Hyun-Seob Jeon, Ga-Young Ban, Hae-Sim Park

Summary: CysLTs play a significant role in type 2 inflammation in the airways of asthmatic patients, leading to the development of AERD, CRS, and asthma severity. Stratification of clinical phenotypes based on uLTE4 levels could help optimize anti-inflammatory therapy for improved asthma control.

ALLERGY ASTHMA & RESPIRATORY DISEASE (2023)

Article Allergy

Nasal Transcriptome and Epigenome Analysis Identifies the Pathogenic Features of Aspirin-Exacerbated Respiratory Disease

Eun-Kyung Kwon, Tae-Wook Kang, Taeyun Oh, Oak-Sung Choo, Young-Min Ye, Hae-Sim Park, Ga-Young Ban

Summary: This study aimed to determine the novel pathogenic features of aspirin-exacerbated respiratory disease (AERD) by performing integrative analysis of transcriptomic and epigenomic profiling with network analysis. The results identified differentially expressed genes and differentially methylated probes between patients with AERD and those with aspirin tolerant asthma (ATA), and revealed the involvement of genes related to vesicle transport and sphingolipid dysregulation in AERD. Furthermore, the study generated signaling pathways related to T helper cell differentiation/activation and Fc epsilon receptor I, and found significant up-regulation of specific genes in AERD compared to ATA. This study provides insights into the distinct pathogenic features of AERD.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2023)

No Data Available